Pharmaceutical compositions
The present disclosure relates to new crystal forms of chemical compounds, formulations including, methods of forming, and methods of using same.
1. A compound, which is resiquimod in the form of a sulfate salt in crystal form A.
2. The compound of claim 1 , wherein the sulfate salt is a monosulfate salt.
3. The compound of claim 1 , wherein the sulfate salt is an anhydrate.
4. The compound of claim 1 , wherein crystal form A is characterized by x-ray powder diffraction (XRPD) spectrum that comprises peaks at about 7 to about 8 degrees 2θ, about 13.5 to about 14.5 degrees 2θ, about 19 to about 20 degrees 2θ, and about 19.5 to about 20.5 degrees 2θ, as determined by XRPD using Cu Kα1 and Cu Kα2 radiation.
5. A dosage form, comprising the compound of claim 1 .
6. The dosage form of claim 5 , which is a solid dosage form.
7. The dosage form of claim 5 , which is a semi-solid dosage form.
8. The dosage form of claim 5 , which is a liquid dosage form.
9. A composition, comprising the compound of claim 1 .
10. A composition, comprising the compound of claim 2 .
11. A composition, comprising the compound of claim 3 .
12. A composition, comprising the compound of claim 4 .
13. A pharmaceutical composition, comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
14. A pharmaceutical composition, comprising the compound of claim 2 and a pharmaceutically acceptable carrier.
15. A pharmaceutical composition, comprising the compound of claim 3 and a pharmaceutically acceptable carrier.
16. A pharmaceutical composition, comprising the compound of claim 4 and a pharmaceutically acceptable carrier.
17. A method of treating a cancer in a subject in need thereof, comprising administering the compound of claim 1 to the subject.
18. A method of treating a tumor in a subject in need thereof, comprising administering the compound of claim 1 to the subject.
19. A method of treating a carcinoma in a subject in need thereof, comprising administering the compound of claim 1 to the subject.
20. A method of treating a sarcoma in a subject in need thereof, comprising administering the compound of claim 1 to the subject.
21. A method of treating a blastoma in a subject in need thereof, comprising administering the compound of claim 1 to the subject.